New name for merged company
American Pharmaceutical Partners, which produces many multisourceinjectable drugs for cancer, critical care, and infection control,has merged with American BioScience to form Abraxis BioScience, LosAngeles. A major drug in its portfolio is the breast cancer drugAbraxane for Injectable Suspension (paclitaxel protein-boundparticles for injectable suspension) (albumin-bound).
American Pharmaceutical Partners, which produces many multisource injectable drugs for cancer, critical care, and infection control, has merged with American BioScience to form Abraxis BioScience, Los Angeles. A major drug in its portfolio is the breast cancer drug Abraxane for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound).
To see more Hot off the Press news articles, click here http://www.drugtopics.com/Hot+off+the+Press.
To go to the Drug Topics homepage, click here http://www.drugtopics.com.
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
